Kadans Science Partner is the European leader investing in the development of ecosystems with a dedicated focus on the knowledge intensive sector. Kadans has invested across various specific areas, like food in Wageningen and life sciences in Leiden, and cell & gene therapy in Stevenage, UK. Kadans provides its tenants with an array of additional services tailored to their specific needs.
Kadans values connection, proximity, sustainability, and human scale. We want to promote innovation by connecting businesses and employees. Both planned and unexpected meetings are promoted. Creating a connecting ‘spine’ between all parts of the research cycle is the basis of our design philosophy.
In December 2020, Kadans was acquired by AXA IM Real Assets which has allowed us to significantly accelerate our growth. AXA is a long term capital partner.
Kadans is currently present on 22 campuses and science parks, in 6 countries, where it operates over 5 million sq ft of space for over 350 tenants, including start-ups, scale- ups, corporates, government bodies and educational institutes. Kadans has a solid view of the developments, our tenants and partners are currently working on and which parties in our network could benefit from connecting.
Kadans Science Partner has added to its Pan-European portfolio after acquiring Merlin Place in Cambridge from a private investor who was represented by Bidwells. This acquisition continues Kadans’ growth in Cambridge following its acquisition of B900 at the Babraham...
Interested in joining UKSPA?
Gain exclusive access to members only resources, research papers, statistics and data – as well as discounted or even free entry to the conferences and events we hold through the year.